Table 4.
Uterine septum versus controls (no septum)—comparative studies.
Study | A Clearly Stated Aim | Inclusion of Consecutive Patients | Prospective Collection of Data | Endpoints Appropriate to the Aim of the Study | Unbiased Assessment of the Study Endpoint | Follow-Up Period Appropriate to the Aim of the Study | Loss to Follow Up less than 5% | Prospective Calculation of the Study Size | An Adequate Control Group | Contemporary Groups | Baseline Equivalence of Groups | Adequate Statistical Analyses | Final Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acien et al., 1993. [14] | ** | ** | ** | ** | * | * | ** | * | * | 14 | |||
Woelfer et al., 2001. [26] | ** | ** | ** | ** | * | * | ** | ** | ** | ** | 18 | ||
Ozgur et al., 2007. [27] | ** | ** | ** | ** | ** | ** | ** | 14 | |||||
Zlopaša et al., 2007. [28] | ** | * | * | ** | * | ** | ** | ** | 13 | ||||
Ban-Frangez et al., 2009. [29] | ** | ** | ** | ** | ** | ** | ** | 14 | |||||
Sugiura-Ogasawara et al., [30] | ** | ** | ** | * | * | ** | ** | ** | ** | 16 | |||
Tomazevic et al., 2010. [31] | ** | ** | * | ** | ** | ** | ** | ** | 15 | ||||
Saravelos et al., 2010. [32] | ** | ** | ** | ** | * | ** | ** | ** | ** | 17 | |||
Jayaprakasan et al., 2011. [33] | ** | ** | ** | ** | * | * | * | ** | ** | ** | ** | 19 | |
Prior et al., 2017. [10] | ** | ** | ** | ** | * | * | ** | ** | ** | ** | ** | ** | 22 |
Each item is scored as “missing” not reported, “*” reported but inadequate; “**” reported and adequate.